Amend 010 - PERTUSSIS VACCINES - GlaxoSmithKline Inc.
Contract number E60PH-21PERT/002/PH
Solicitation number E60PH-21PERT
Contract award date
Expiry date
Amendment date
Amendment value CAD 18,699,776.08
Contract number E60PH-21PERT/002/PH
Solicitation number E60PH-21PERT
Contract award date
Expiry date
Amendment date
Amendment value CAD 18,699,776.08
The contract will be for a period of 62 month(s), from 2021/01/05 to 2026/03/31.
This is the total value of this contract, which includes the initial contract value and the sum of all amendments.
CAD 69,222,397.88
A contracting officer can use limited tendering for specific reasons outlined in the applicable trade agreements. The reason for this contract is described below: